 Matthew Wortham
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 7 | 2023 | 367 | 2.560 |
Why?
| | Otx Transcription Factors | 3 | 2014 | 13 | 0.940 |
Why?
| | Medulloblastoma | 4 | 2014 | 198 | 0.870 |
Why?
| | Islets of Langerhans | 4 | 2024 | 791 | 0.810 |
Why?
| | Cerebellar Neoplasms | 3 | 2014 | 156 | 0.810 |
Why?
| | Gene Expression Regulation | 5 | 2019 | 2548 | 0.640 |
Why?
| | Protein Processing, Post-Translational | 3 | 2023 | 455 | 0.610 |
Why?
| | Insulin | 7 | 2024 | 2326 | 0.570 |
Why?
| | Cellular Senescence | 1 | 2018 | 181 | 0.540 |
Why?
| | Insulin Resistance | 4 | 2024 | 1165 | 0.540 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2441 | 0.530 |
Why?
| | Fasting | 1 | 2016 | 267 | 0.460 |
Why?
| | Retinoids | 1 | 2014 | 33 | 0.460 |
Why?
| | Metabolomics | 1 | 2018 | 652 | 0.420 |
Why?
| | Chromatin | 3 | 2023 | 479 | 0.410 |
Why?
| | Proteomics | 2 | 2018 | 1062 | 0.410 |
Why?
| | Testosterone | 1 | 2016 | 372 | 0.400 |
Why?
| | Adaptation, Physiological | 1 | 2016 | 513 | 0.400 |
Why?
| | Rhombencephalon | 1 | 2012 | 30 | 0.380 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2014 | 1356 | 0.350 |
Why?
| | Glucose | 5 | 2024 | 1003 | 0.340 |
Why?
| | Neural Stem Cells | 1 | 2012 | 143 | 0.340 |
Why?
| | Food, Formulated | 1 | 2008 | 14 | 0.300 |
Why?
| | S-Adenosylmethionine | 1 | 2008 | 55 | 0.290 |
Why?
| | Hepatitis | 1 | 2008 | 47 | 0.290 |
Why?
| | Blood Glucose | 2 | 2021 | 2097 | 0.290 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2007 | 14 | 0.280 |
Why?
| | Animals | 17 | 2024 | 35361 | 0.280 |
Why?
| | Cell Movement | 1 | 2012 | 945 | 0.280 |
Why?
| | Stem Cells | 2 | 2022 | 577 | 0.280 |
Why?
| | Methionine | 1 | 2008 | 158 | 0.280 |
Why?
| | Xenobiotics | 1 | 2007 | 29 | 0.280 |
Why?
| | Choline | 1 | 2008 | 124 | 0.270 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2007 | 151 | 0.260 |
Why?
| | Mice | 12 | 2024 | 16937 | 0.260 |
Why?
| | Histones | 2 | 2023 | 588 | 0.250 |
Why?
| | Fatty Liver | 1 | 2008 | 231 | 0.240 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 217 | 0.240 |
Why?
| | Signal Transduction | 6 | 2023 | 4925 | 0.240 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1706 | 0.240 |
Why?
| | Tyrosine-tRNA Ligase | 1 | 2024 | 5 | 0.230 |
Why?
| | Liver | 3 | 2022 | 1839 | 0.220 |
Why?
| | Histone Demethylases | 2 | 2022 | 31 | 0.220 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2024 | 63 | 0.210 |
Why?
| | Neurons | 1 | 2012 | 1511 | 0.210 |
Why?
| | Histone Code | 1 | 2023 | 31 | 0.210 |
Why?
| | Transcription Factors | 3 | 2020 | 1651 | 0.190 |
Why?
| | Cell Differentiation | 3 | 2021 | 1902 | 0.190 |
Why?
| | Proinsulin | 1 | 2021 | 52 | 0.180 |
Why?
| | Hearing Loss | 1 | 2024 | 210 | 0.180 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2021 | 133 | 0.180 |
Why?
| | Endocrine Cells | 1 | 2020 | 7 | 0.170 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2022 | 261 | 0.160 |
Why?
| | Gene Silencing | 1 | 2020 | 190 | 0.160 |
Why?
| | Tretinoin | 1 | 2020 | 130 | 0.160 |
Why?
| | Homeostasis | 2 | 2016 | 611 | 0.160 |
Why?
| | Endoplasmic Reticulum | 1 | 2021 | 261 | 0.160 |
Why?
| | Obesity | 3 | 2022 | 2883 | 0.150 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 177 | 0.150 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 55 | 0.150 |
Why?
| | Cell Respiration | 1 | 2018 | 98 | 0.150 |
Why?
| | Carrier Proteins | 1 | 2021 | 743 | 0.140 |
Why?
| | Carbon | 1 | 2018 | 210 | 0.140 |
Why?
| | Interleukin-1beta | 1 | 2019 | 372 | 0.140 |
Why?
| | Allosteric Regulation | 1 | 2016 | 99 | 0.130 |
Why?
| | Pancreas | 1 | 2018 | 306 | 0.130 |
Why?
| | Diabetes Mellitus | 1 | 2024 | 1001 | 0.120 |
Why?
| | Mice, Inbred C57BL | 3 | 2022 | 5440 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2021 | 1119 | 0.120 |
Why?
| | Receptors, Androgen | 1 | 2016 | 147 | 0.120 |
Why?
| | Chromosome Structures | 1 | 2014 | 2 | 0.120 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2014 | 20 | 0.110 |
Why?
| | Tissue Engineering | 1 | 2018 | 396 | 0.110 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2014 | 132 | 0.110 |
Why?
| | Proteome | 1 | 2018 | 443 | 0.110 |
Why?
| | Humans | 13 | 2024 | 129650 | 0.110 |
Why?
| | Receptors, Cell Surface | 1 | 2016 | 380 | 0.110 |
Why?
| | Hedgehog Proteins | 2 | 2012 | 188 | 0.110 |
Why?
| | Tumor Cells, Cultured | 1 | 2014 | 940 | 0.100 |
Why?
| | Deoxyribonuclease I | 1 | 2012 | 38 | 0.100 |
Why?
| | Lipid Metabolism | 2 | 2022 | 497 | 0.100 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2012 | 87 | 0.100 |
Why?
| | Trans-Activators | 1 | 2014 | 388 | 0.090 |
Why?
| | Hydrogels | 1 | 2018 | 638 | 0.090 |
Why?
| | Hyperplasia | 1 | 2012 | 171 | 0.090 |
Why?
| | Primates | 1 | 2012 | 120 | 0.090 |
Why?
| | Cerebellum | 1 | 2012 | 219 | 0.080 |
Why?
| | Male | 7 | 2024 | 63681 | 0.080 |
Why?
| | Promoter Regions, Genetic | 1 | 2014 | 1207 | 0.080 |
Why?
| | DNA Methylation | 1 | 2014 | 607 | 0.080 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 424 | 0.080 |
Why?
| | Models, Biological | 1 | 2016 | 1722 | 0.080 |
Why?
| | Aging | 1 | 2018 | 1776 | 0.070 |
Why?
| | Evolution, Molecular | 1 | 2012 | 466 | 0.070 |
Why?
| | Mice, Obese | 1 | 2008 | 59 | 0.070 |
Why?
| | Female | 6 | 2021 | 68776 | 0.070 |
Why?
| | Mice, Mutant Strains | 1 | 2008 | 298 | 0.070 |
Why?
| | Microsomes, Liver | 1 | 2007 | 87 | 0.070 |
Why?
| | Isoenzymes | 1 | 2007 | 302 | 0.060 |
Why?
| | Glutathione | 1 | 2008 | 348 | 0.060 |
Why?
| | Transcription, Genetic | 1 | 2012 | 1418 | 0.060 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1443 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 958 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2021 | 2871 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2012 | 2391 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2012 | 3083 | 0.060 |
Why?
| | Disease Progression | 2 | 2009 | 2635 | 0.050 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2023 | 63 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2024 | 582 | 0.050 |
Why?
| | Protein Aggregates | 1 | 2021 | 67 | 0.040 |
Why?
| | Lysosomes | 1 | 2021 | 138 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 356 | 0.040 |
Why?
| | Lysine | 1 | 2022 | 286 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2021 | 239 | 0.040 |
Why?
| | Human Embryonic Stem Cells | 1 | 2020 | 23 | 0.040 |
Why?
| | Cell Line | 2 | 2018 | 2781 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 3215 | 0.040 |
Why?
| | Protein Folding | 1 | 2021 | 266 | 0.040 |
Why?
| | Maf Transcription Factors, Large | 1 | 2019 | 6 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2007 | 2708 | 0.040 |
Why?
| | Urocortins | 1 | 2019 | 22 | 0.040 |
Why?
| | Tissue Survival | 1 | 2018 | 16 | 0.040 |
Why?
| | Autophagy | 1 | 2021 | 268 | 0.040 |
Why?
| | Pepsin A | 1 | 2018 | 19 | 0.040 |
Why?
| | Lipids | 1 | 2022 | 625 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 697 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2024 | 874 | 0.040 |
Why?
| | Sulfates | 1 | 2018 | 50 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2018 | 84 | 0.040 |
Why?
| | Fluorescence | 1 | 2018 | 160 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2008 | 4063 | 0.040 |
Why?
| | Base Sequence | 1 | 2020 | 2142 | 0.030 |
Why?
| | Swine | 1 | 2018 | 760 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2007 | 5762 | 0.030 |
Why?
| | Biomarkers | 1 | 2007 | 3973 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 821 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 613 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2018 | 504 | 0.030 |
Why?
| | Infant | 1 | 2007 | 9024 | 0.030 |
Why?
| | S100 Proteins | 1 | 2012 | 36 | 0.030 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 21 | 0.030 |
Why?
| | Child, Preschool | 1 | 2007 | 10517 | 0.020 |
Why?
| | Nucleotide Motifs | 1 | 2012 | 33 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2736 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 315 | 0.020 |
Why?
| | Adult | 2 | 2020 | 35576 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 575 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2012 | 249 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5500 | 0.020 |
Why?
| | Genome, Human | 1 | 2012 | 393 | 0.020 |
Why?
| | Genes, myc | 1 | 2009 | 50 | 0.020 |
Why?
| | Gene Dosage | 1 | 2009 | 143 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 1252 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2009 | 315 | 0.020 |
Why?
| | Adolescent | 1 | 2007 | 20393 | 0.020 |
Why?
| | Aged | 1 | 2007 | 22103 | 0.020 |
Why?
| | Mice, Nude | 1 | 2009 | 683 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 769 | 0.020 |
Why?
| | Child | 1 | 2007 | 20883 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1205 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1038 | 0.020 |
Why?
| | Protein Binding | 1 | 2012 | 2121 | 0.020 |
Why?
| | Middle Aged | 1 | 2007 | 31154 | 0.020 |
Why?
| | Phenotype | 1 | 2012 | 3076 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 12426 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2009 | 2073 | 0.010 |
Why?
| | Mutation | 1 | 2012 | 3717 | 0.010 |
Why?
|
|
Wortham's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|